Literature DB >> 19767772

Regulation of miRNA expression by Src and contact normalization: effects on nonanchored cell growth and migration.

X Li1, Y Shen, H Ichikawa, T Antes, G S Goldberg.   

Abstract

Transformation by the Src tyrosine kinase (Src) promotes nonanchored cell growth and migration. However, nontransformed cells can force Src-transformed cells to assume a normal morphology and phenotype by a process called 'contact normalization'. It has become clear that microRNA (miRNA) can affect tumorigenesis by targeting gene products that direct cell growth and migration. However, the roles of miRNA in Src transformation or contact normalization have not yet been reported. We examined the expression of 95 miRNAs and found 9 of them significantly affected by Src. In this study, we report that miR-218 and miR-224 were most significantly induced by Src, but not affected by contact normalization. In contrast, miR-126 was most significantly suppressed by Src and was induced by contact normalization in transformed cells. Mir-126 targets Crk, a component of the focal adhesion network that participates in events required for tumor cell migration. Accordingly, we show that miR-126 expression correlates inversely with Crk levels, motility and the invasive potential of human mammary carcinoma cells. Moreover, we show that miR-224 expression promotes nonanchored growth of nontransformed cells. These data reveal novel insights into how Src regulates miRNA expression to promote hallmarks of tumor cell growth and invasion, and how nontransformed cells can affect miRNA expression in adjacent tumor cells to inhibit this process.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19767772     DOI: 10.1038/onc.2009.278

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  27 in total

1.  MMSET stimulates myeloma cell growth through microRNA-mediated modulation of c-MYC.

Authors:  D-J Min; T Ezponda; M K Kim; C M Will; E Martinez-Garcia; R Popovic; V Basrur; K S Elenitoba-Johnson; J D Licht
Journal:  Leukemia       Date:  2012-09-13       Impact factor: 11.528

Review 2.  Role of microRNAs in breast cancer.

Authors:  Ramesh Singh; Yin-Yuan Mo
Journal:  Cancer Biol Ther       Date:  2013-01-04       Impact factor: 4.742

Review 3.  Mechanisms of environmental chemicals that enable the cancer hallmark of evasion of growth suppression.

Authors:  Rita Nahta; Fahd Al-Mulla; Rabeah Al-Temaimi; Amedeo Amedei; Rafaela Andrade-Vieira; Sarah N Bay; Dustin G Brown; Gloria M Calaf; Robert C Castellino; Karine A Cohen-Solal; Annamaria Colacci; Nichola Cruickshanks; Paul Dent; Riccardo Di Fiore; Stefano Forte; Gary S Goldberg; Roslida A Hamid; Harini Krishnan; Dale W Laird; Ahmed Lasfar; Paola A Marignani; Lorenzo Memeo; Chiara Mondello; Christian C Naus; Richard Ponce-Cusi; Jayadev Raju; Debasish Roy; Rabindra Roy; Elizabeth P Ryan; Hosni K Salem; A Ivana Scovassi; Neetu Singh; Monica Vaccari; Renza Vento; Jan Vondráček; Mark Wade; Jordan Woodrick; William H Bisson
Journal:  Carcinogenesis       Date:  2015-06       Impact factor: 4.944

4.  MicroRNA-224 is up-regulated in hepatocellular carcinoma through epigenetic mechanisms.

Authors:  Yu Wang; Han Chong Toh; Pierce Chow; Alexander Y F Chung; David J Meyers; Philip A Cole; London L P J Ooi; Caroline G L Lee
Journal:  FASEB J       Date:  2012-03-29       Impact factor: 5.191

5.  Emerging roles for crk in human cancer.

Authors:  Ganapathy Sriram; Raymond B Birge
Journal:  Genes Cancer       Date:  2010-11

6.  SRC points the way to biomarkers and chemotherapeutic targets.

Authors:  Harini Krishnan; W Todd Miller; Gary S Goldberg
Journal:  Genes Cancer       Date:  2012-05

Review 7.  The role of microRNA in castration-resistant prostate cancer.

Authors:  William Thieu; Derya Tilki; Ralph de Vere White; Christopher P Evans
Journal:  Urol Oncol       Date:  2014-07       Impact factor: 3.498

8.  MicroRNA-224 targets SMAD family member 4 to promote cell proliferation and negatively influence patient survival.

Authors:  Yu Wang; Jianwei Ren; Yun Gao; Joel Z I Ma; Han Chong Toh; Pierce Chow; Alexander Y F Chung; London L P J Ooi; Caroline G L Lee
Journal:  PLoS One       Date:  2013-07-29       Impact factor: 3.240

9.  Upregulation of microRNA-224 confers a poor prognosis in glioma patients.

Authors:  S Lu; S Wang; S Geng; S Ma; Z Liang; B Jiao
Journal:  Clin Transl Oncol       Date:  2012-12-21       Impact factor: 3.405

10.  miR-30 as a tumor suppressor connects EGF/Src signal to ERG and EMT.

Authors:  C-J Kao; A Martiniez; X-B Shi; J Yang; C P Evans; A Dobi; R W deVere White; H-J Kung
Journal:  Oncogene       Date:  2013-06-03       Impact factor: 9.867

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.